Symptom dimensions and functional impairment in early psychosis: More to the story than just negative symptoms

Schizophrenia Research

Volumn 147, Issue 1, 2013, Pages 125-131

  Fulford, Daniel ^a   Niendam, Tara A ^b   Floyd, Erin G ^b   Carter, Cameron S ^b   Mathalon, Daniel H ^a,c   Vinogradov, Sophia ^a,c   Stuart, Barbara K ^a   Loewy, Rachel L ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c San Francisco VA Healthcare System   (United States)

Author keywords

Clinical high risk; Depression; Negative symptoms; Psychosocial functioning; Recent onset psychosis; Schizophrenia

Indexed keywords

ADOLESCENT; ADULT; ANXIETY; ARTICLE; BRIEF PSYCHIATRIC RATING SCALE; CHILD; CLINICAL GLOBAL IMPRESSION SCALE; CONTROLLED STUDY; DEPRESSION; FEMALE; FUNCTIONAL DISEASE; HIGH RISK PATIENT; HUMAN; MAJOR CLINICAL STUDY; MALE; NEGATIVE SYNDROME; PRESCHOOL CHILD; PRIORITY JOURNAL; PSYCHOSIS; RATING SCALE; SCHOOL CHILD; SOCIAL PSYCHOLOGY; STRAUSS CARPENTER OUTCOME SCALE; SYMPTOMATOLOGY;

ADOLESCENT; ADULT; CHILD; FEMALE; HUMANS; MALE; PREDICTIVE VALUE OF TESTS; PSYCHIATRIC STATUS RATING SCALES; PSYCHOTIC DISORDERS; REGRESSION ANALYSIS; RISK FACTORS; SCHIZOPHRENIA; SOCIAL ADJUSTMENT; YOUNG ADULT;

EID: 84877151288     PISSN: 09209964     EISSN: 15732509     Source Type: Journal    
DOI: 10.1016/j.schres.2013.03.024     Document Type: Article

References (63)

1. Achim A.M., Maziade M., Raymond E., Olivier D., Mérette C., Roy M.A. How prevalent are anxiety disorders in schizophrenia? A meta-analysis and critical review on a significant association. Schizophr. Bull. 2011, 37(4):811-821.
2. Addington D., Addington J., Maticka-Tyndale E., Joyce J. Reliability and validity of a depression rating scale for schizophrenics. Schizophr. Res. 1992, 6(3):201-208.
3. Addington J., Epstein I., Liu L., French P., Boydell K.M., Zipursky R.B. A randomized controlled trial of cognitive behavioral therapy for individuals at clinical high risk of psychosis. Schizophr. Res. 2011, 125(1):54-61.
4. Amminger G.P., Leicester S., Yung A.R., Phillips L.J., Berger G.E., Francey S.M., McGorry P.D. Early-onset of symptoms predicts conversion to non-affective psychosis in ultra-high risk individuals. Schizophr. Res. 2006, 84(1):67-76.
5. Andreasen N.C. Scale for the Assessment of Negative Symptoms (SANS) 1983, University of Iowa, Iowa City, IA.
6. Andreasen N.C. Scale for the Assessment of Positive Symptoms (SAPS) 1984, University of Iowa, Iowa City, IA.
7. Andreasen N.C., Arndt S., Alliger R., Miller D. Symptoms of schizophrenia: methods, meanings, and mechanisms. Arch. Gen. Psychiatry 1995, 52(5):341-351.
8. Arndt S., Turvey C., Andreasen N.C. Correlating and predicting psychiatric symptom ratings: Spearman's r versus Kendall's tau correlation. J. Psychiatr. Res. 1999, 33(2):97-104.
9. Auther A.M., Smith C.W., Cornblatt B.A. Global Functioning: Social Scale (GF: Social) 2006, Zucker-Hillside Hospital, Glen Oaks, NY.
10. Barch D.M., Carter C.S., MacDonald A.W., Braver T.S., Cohen J.D. Context-processing deficits in schizophrenia: diagnostic specificity, 4-week course, and relationships to clinical symptoms. J. Abnorm. Psychol. 2003, 112(1):132-143.
11. Bechdolf A., Wagner M., Veith V., Ruhrmann S., Pukrop R., Brockhaus-Dumke A., Berning J., Stamm E., Janssen B., Decker P., Bottlender R., Moller J., Gaebel W., Maier W., Klosterkötter J. Randomized controlled multicentre trial of cognitive behaviour therapy in the early initial prodromal state: effects on social adjustment post treatment. Early Interv. Psychiatry 2008, 1(1):71-78.
12. Bourdeau G., Masse M., Lecomte T. Social functioning in early psychosis: are all the domains predicted by the same variables?. Early Interv. Psychiatry 2012, 6:317-321.
13. Braga R.J., Mendlowicz M.V., Marrocos R.P., Figueira I.L. Anxiety disorders in outpatients with schizophrenia: prevalence and impact on the subjective quality of life. J. Psychiatr. Res. 2005, 39(4):409-414.
14. Brekke J.S., DeBonis J.A., Graham J.W. A latent structure analysis of the positive and negative symptoms in schizophrenia. Compr. Psychiatry 1994, 35(4):252-259.
15. Cannon T.D., Cadenhead K., Cornblatt B., Woods S.W., Addington J., Walker E., Seidman L.J., Perkins D., Tsuang M., McGlashan T., Heinssen R. Prediction of psychosis in youth at high clinical risk: a multisite longitudinal study in North America. Arch. Gen. Psychiatry 2008, 65(1):28-37.
16. Corcoran C.M., Kimhy D., Parrilla-Escobar M.A., Cressman V.L., Stanford A.D., Thompson J., Ben David S., Crumbley A., Schobel S., Moore H., Malaspina D. The relationship of social function to depressive and negative symptoms in individuals at clinical high risk for psychosis. Psychol. Med. 2011, 41(2):251-261.
17. Cornblatt B.A., Auther A.M., Niendam T., Smith C.W., Zinberg J., Bearden C.E., Cannon T.D. Preliminary findings for two new measures of social and role functioning in the prodromal phase of schizophrenia. Schizophr. Bull. 2007, 33(3):688-702. (BP).
18. Dickerson F.B., Ringel N.B., Parente F. Subjective quality of life in out-patients with schizophrenia: clinical and utilization correlates. Acta Psychiatr. Scand. 1998, 98(2):124-127.
19. Dragt S., Nieman D.H., Veltman D., Becker H.E., van de Fliert R., de Haan L., Linszen D.H. Environment factors and social adjustment as predictors of a first psychosis in subjects at ultra high risk. Schizophr. Res. 2011, 125(1):69-76.
20. Eslami A., Jahshan C., Cadenhead K.S. Disorganized symptoms and executive functioning predict impaired social functioning in subjects at risk for psychosis. J. Neuropsychiatry Clin. Neurosci. 2011, 23(4):457-460.
21. First M.B., Spitzer R.L., Gibbon M., Williams J.B.W. Structured Clinical Interview for DSM-IV-TR Axis I Disorders, Research Version, Patient Edition (SCID-I/P) 2002, Biometrics Research, New York State Psychiatric Institute, New York.
22. Fusar-Poli P., Bonoldi I., Yung A.R., Borgwardt S., Kempton M.J., Valmaggia L., Barale F., Caverzasi E., McGuire P. Predicting psychosis: meta-analysis of transition outcomes in individuals at high clinical risk. Arch. Gen. Psychiatry 2012, 69(3):220-229.
23. Fusar-Poli P., Bechdolf A., Taylor M.J., Bonoldi I., Carpenter W.T., Yung A.R., McGuire P. At risk for schizophrenic or affective psychoses?. Schizophr. Bull. 2013, (in press).
24. Häfner H., Löffler W., Maurer K., Hambrecht M., an der Heiden W. Depression, negative symptoms, social stagnation and social decline in the early course of schizophrenia. Acta Psychiatr. Scand. 1999, 100(2):105-118.
25. Häfner H., Maurer K., Löffler W., an der Heiden W., Könnecke R., Hambrecht M. The early course of schizophrenia. Risk and Protective Factors in Schizophrenia 2002, 207-228. Steinkopff-Verlag, Darmstadt. H. Häfner (Ed.).
26. Hall R.C.W. Global assessment of functioning: a modified scale. Psychosomatics 1995, 36(3):267-275.
27. Haroun N., Dunn L., Haroun A., Cadenhead K.S. Risk and protection in prodromal schizophrenia: ethical implications for clinical practice and future research. Schizophr. Bull. 2006, 32(1):166-178. (BP).
28. Kaufman J., Birmaher B., Brent D., Rao U., Ryan N. K-SADS-PL (Retrieved from). http://www.wpic.pitt.edu/ksads/default.htm.
29. Keshavan M.S., Haas G., Miewald J., Montrose D.M., Reddy V., Schooler N.R., Sweeney J.A. Prolonged untreated illness duration from prodromal onset predicts outcome in first episode psychoses. Schizophr. Bull. 2003, 29(4):757-769. (BP).
30. Kim K.R., Lee S.Y., Kang J.I., Kim B.R., Choi S., Park J.Y., Lee E., An S.K., Kwon J.S. Clinical efficacy of individual cognitive therapy in reducing psychiatric symptoms in people at ultra-high risk for psychosis. Early Interv. Psychiatry 2011, 5(2):174-178.
31. Klaassen R.M.C., Velthorst E., Nieman D.H., de Haan L., Becker H.E., Dingemans P.M., van de Fliert J.R., van der Gaag M., Linszen D.H. Factor analysis of the scale of prodromal symptoms: differentiating between negative and depression symptoms. Psychopathology 2011, 44(6):379-385.
32. Liddle P.F. The symptoms of chronic schizophrenia: a re-examination of the positive-negative dichotomy. Br. J. Psychiatry 1987, 151:145-151.
33. McGlashan T.H., Johannessen J.O. Early detection and intervention with schizophrenia: rationale. Schizophr. Bull. 1996, 22:201-222. (BP).
34. McGlashan T.H., Miller T.J., Woods S.W. Pre-onset detection and intervention research in schizophrenia psychoses: current estimates of benefit and risk. Schizophr. Bull. 2001, 27(4):563-570. (BP).
35. Meyer S.E., Bearden C.E., Lux S.R., Gordon J.L., Johnson J.K., O'Brien M.P., Niendam T.A., Loewy R.L., Ventura J., Cannon T.D. The psychosis prodrome in adolescent patients viewed through the lens of DSM-IV. J. Child Adolesc. Psychopharmacol. 2005, 15:434-451.
36. Morrison A.P., French P., Walford L., Lewis S.W., Kilcommons A., Green J., Parker S., Bentall R.P. Cognitive therapy for the prevention of psychosis in people at ultra-high risk: randomised controlled trial. Br. J. Psychiatry 2004, 185(4):291-297.
37. Morrison A.P., French P., Parker S., Roberts M., Stevens H., Bentall R.P., Lewis S.W. Three-year follow-up of a randomized controlled trial of cognitive therapy for the prevention of psychosis in people at ultrahigh risk. Schizophr. Bull. 2007, 33(3):682-687. (BP).
38. Muller J.E., Koen L., Seedat S., Emsley R.A., Stein D.J. Anxiety disorders and schizophrenia. Curr. Psychiatry Rep. 2004, 6(4):255-261.
39. Niendam T.A., Bearden C.E., Johnson J.K., Cannon T.D. Global Functioning: Role Scale (GF: Role) 2006, University of California, Los Angeles, Los Angeles, CA.
40. Niendam T.A., Bearden C.E., Johnson J.K., McKinley M., Loewy R., O'Brien M., Nuechterlein K.H., Green M.F., Cannon T.D. Neurocognitive performance and functional disability in the psychosis prodrome. Schizophr. Res. 2006, 84(1):100-111.
41. Niendam T.A., Bearden C.E., Zinberg J., Johnson J.K., O'Brien M., Cannon T.D. The course of neurocognition and social functioning in individuals at ultra high risk for psychosis. Schizophr. Bull. 2007, 33(3):772-781. (BP).
42. Norman R.M.G., Malla A.K., Cortese L., Cheng S., Diaz K., McIntosh E., McLean T.S., Rickwood A., Voruganti L.P. Symptoms and cognition as predictors of community functioning: a prospective analysis. Am. J. Psychiatry 1999, 156(3):400-405.
43. Norman R.M.G., Malla A.K., McLean T., Voruganti L.P.N., Cortese L., McIntosh E., Cheng S., Rickwood A. The relationship of symptoms and level of functioning in schizophrenia to general wellbeing and the quality of life scale. Acta Psychiatr. Scand. 2000, 102(4):303-309.
44. Overall J.E., Gorham D.R. The brief psychiatric rating scale. Psychol. Rep. 1962, 10:799-812.
45. Peles E., Schreiber S., Naumovsky Y., Adelson M. Depression in methadone maintenance treatment patients: rate and risk factors. J. Affect. Disord. 2007, 99(1-3):213-220.
46. Pinikahana J., Happell B., Hope J., Keks N.A. Quality of life in schizophrenia: a review of the literature from 1995 to 2000. Int. J. Ment. Health Nurs. 2002, 11(2):103-111.
47. Piskulic D., Addington J., Cadenhead K.S., Cannon T.D., Cornblatt B.A., Heinssen R., Perkins D.O., Seidman L.J., Tsuang M.T., Walker E.F., Woods S.W., McGlashan T.H. Negative symptoms in individuals at clinical high risk of psychosis. Psychiatry Res. 2012, 196(2-3):220-224.
48. Rosen J.L., Miller T.J., D'Andrea J.T., McGlashan T.H., Woods S.W. Comorbid diagnoses in patients meeting criteria for the schizophrenia prodrome. Schizophr. Res. 2006, 85(1-3):124-131.
49. Ruhrmann S., Schultze-Lutter F., Salokangas R.K., Heinimaa M., Linsze D., Dingemans, Klosterkötter J. Prediction of psychosis in adolescents and young adults at high risk: results from the prospective European prediction of psychosis study. Arch. Gen. Psychiatry 2010, 67(3):241-251.
50. Saarni S.I., Viertiö S., Perala J., Koskinen S., Lönnqvist J., Suvisaari J. Quality of life of people with schizophrenia, bipolar disorder and other psychotic disorders. Br. J. Psychiatry 2010, 197(5):386-394.
51. Sakiyama S., Iida J., Minami Y., Kishimoto T. Factors of good outcome after discharge from support house (engoryu) for schizophrenia. Psychiatry Clin. Neurosci. 2002, 56(6):609-615.
52. Salokangas R.K., Ruhrmann S., von Reventlow H.G., Heinimaa M., Svirskis T., From T., EPOS group Axis I diagnoses and transition to psychosis in clinical high-risk patients EPOS project: prospective follow-up of 245 clinical high-risk outpatients in four countries. Schizophr. Res. 2012, 138(2-3):192-197.
53. Sands J.R., Harrow M. Depression during the longitudinal course of schizophrenia. Schizophr. Bull. 1999, 25(1):157-171. (BP).
54. Schlosser D.A., Jacobson S., Chen Q., Sugar C.A., Niendam T.A., Li G., Bearden C.E., Cannon T.D. Recovery from an at-risk state: clinical and functional outcomes of putatively prodromal youth who do not develop psychosis. Schizophr. Bull. 2012, 38(6):1225-1233.
55. Strauss J.S., Carpenter W.T. The prediction of outcome in schizophrenia: I. Characteristics of outcome. Arch. Gen. Psychiatry 1972, 27(6):739-746.
56. Svirskis T., Korkeila J., Heinimaa M., Huttunen J., Ilonen T., Ristkari T., Hietala J., Syvälahti E., McGlashan T., Vahlberg T., Salokangas R.K.R. Quality of life and functioning ability in subjects vulnerable to psychosis. Compr. Psychiatry 2007, 48(2):155-160.
57. Takahashi H., Iwase M., Nakahachi T., Sekiyama R., Tabushi K., Kajimoto O., Shimizu A., Takeda M. Spatial working memory deficit correlates with disorganization symptoms and social functioning in schizophrenia. Psychiatry Clin. Neurosci. 2005, 59(4):453-460.
58. Velthorst E., Nieman D.H., Linszen D., Becker H., de Haan L., Dingemans P.M., Birchwood M., Patterson P., Salokangas R.K.R., Heinimaa M., Heinz A., Juckel G., von Reventlow H.G., French P., Stevens H., Schultze-Lutter F., Klosterkötter J., Ruhrmann S. Disability in people clinically at high risk of psychosis. Br. J. Psychiatry 2010, 197(4):278-284.
59. Ventura J., Hellemann G.S., Thames A.D., Koellner V., Nuechterlein K.H. Symptoms as mediators of the relationship between neurocognition and functional outcome in schizophrenia: a meta-analysis. Schizophr. Res. 2009, 113(2-3):189-199.
60. Yung A.R., McGorry P.D. The initial prodrome in psychosis: descriptive and qualitative aspects. Aust. N. Z. J. Psychiatry 1996, 30(5):587-599.
61. Yung A.R., Phillips L.J., Yuen H.P., McGorry P.D. Risk factors for psychosis in an ultra high-risk group: psychopathology and clinical features. Schizophr. Res. 2004, 67(2-3):131-142.
62. Yung A.R., Buckby J.A., Cosgrave E.M., Killackey E.J., Baker K., Cotton S.M., McGorry P.D. Association between psychotic experiences and depression in a clinical sample over 6months. Schizophr. Res. 2007, 91(1-3):246-253.
63. Yung A.R., Nelson B., Thompson A., Wood S.J. The psychosis threshold in ultra high risk (prodromal) research: is it valid?. Schizophr. Res. 2010, 120(1-3):1-6.